AWM Investment Company’s Tempest Therapeutics TPST Stock Holding History
Bought
Maintained
Sold
Other funds holding TPST
NMC
CC
GTC
AFM
GPP
BCM
AWM Investment Company's TPST Position: Q4 2020 in Review
AWM Investment Company sold out of Tempest Therapeutics (TPST) in Q4 2020, closing a stake of 1,021 shares — an estimated $324K sold.
AWM Investment Company first reported a position in TPST in Q4 2014 and held it in 22 quarters. The position peaked at $4.12M in Q4 2019. 37 funds tracked by Wall St. Rank hold TPST as of Q4 2020.
- AWM Investment Company reported no remaining Tempest Therapeutics position as of Q4 2020 after selling out during the quarter.
- AWM Investment Company sold 1,021 Tempest Therapeutics shares in Q4 2020, an estimated $324K.
- AWM Investment Company first reported a position in Tempest Therapeutics in Q4 2014 and held it in 22 quarters.
- AWM Investment Company's Tempest Therapeutics position peaked at $4.12M in Q4 2019.
- 37 funds tracked by Wall St. Rank held Tempest Therapeutics as of Q4 2020.
Based on AWM Investment Company's 13F filing for Q4 2020, filed 12 Feb 2021.